Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
STOCKHOLM, SE / ACCESSWIRE / January 28, 2022 / Vimian Group (STO:VIMIAN)Vimian Group has today signed an agreement to acquire...
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Toronto, Ontario--(Newsfile Corp. - January 28, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
RICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology...
Focus will be on staffing challenges, community engagement, provider wellness and evolving service delivery models AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading...
SAN FRANCISCO--(BUSINESS WIRE)--#Healthcare--Perspectum announced recruitment of the first patient in a multi-center collaborative study to characterize Primary Sclerosing Cholangitis in...
IRVINE, CA / ACCESSWIRE / January 28, 2022 / CardieX Limited (ASX:CDX)(OTC PINK:CDEXF) ("CardieX" or the "Company",) a global health-technology...
ORLANDO, FL / ACCESSWIRE / January 28, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the receipt of an Issue Notification...
STI-1558, a novel oral Mpro inhibitor, effectively inhibits Omicron virus entry and replication in cells.STI-1558 is orally bioavailable with improved...
A renowned speaker, and bestselling author, Dr. Gabor Maté is highly sought after for his expertise on a range of...
MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene...
Brings Significant Operational Experience in Building Therapeutic Drug Development BusinessesTUCSON, Ariz., Jan. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc....
MONMOUTH JUNCTION, N.J., Jan. 28, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the...
Amryt Announces Oleogel-S10 EMA Regulatory Update Ad-Hoc Expert Group to provide independent EB specific expertise and advice DUBLIN, Ireland, and...
UTRECHT, The Netherlands and PHILADELPHIA, Jan. 28, 2022 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company...
VANCOUVER, British Columbia, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
University Hospital Brandenburg an der Havel January 28, 2022 Major German University Hospital secures long-term access to the latest health...
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing...
Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology...